Evaluation of the Implementation of the UK Antimicrobial Resistance (AMR) Strategy, 2013-2018

  29 April 2020

The aims of the Strategy were to be achieved through activity in seven areas: improving infection prevention and control; optimising prescribing practice; improving professional education, training and public engagement; developing new drugs, treatments and diagnostics; better access to and use of surveillance data; better identification and prioritisation of research needs; and strengthened international
collaboration. The Strategy was developed within a One Health approach,2 thus the scope of the Strategy included issues relevant to human health, animal health and husbandry, agriculture, and the wider environment.

Author(s): Policy Innovation and Evaluation Research Unit
Effective Surveillance  
Back

OUR UNDERWRITERS

Unrestricted financial support by:

Antimicrobial Resistance Fighter Coalition

Evotec

JSS University





Technology Database

Display your AMR Technology, Product and Service

Suppliers and Users of Technologies, Products and Services benefit from CAPI.
CAPI (Continuous AMR Partnering Initiative) unites Suppliers and Users worldwide with the aim to add to the curbing of AMR.

Read more and make your own Technology Page >>
What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!